98 related articles for article (PubMed ID: 20073996)
1. CYP2E1 and risk of chemically mediated cancers.
Trafalis DT; Panteli ES; Grivas A; Tsigris C; Karamanakos PN
Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):307-19. PubMed ID: 20073996
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity.
Neafsey P; Ginsberg G; Hattis D; Johns DO; Guyton KZ; Sonawane B
J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):362-88. PubMed ID: 20183527
[TBL] [Abstract][Full Text] [Related]
3. Association of CYP2E1 gene polymorphism with predisposition to cancer development.
Danko IM; Chaschin NA
Exp Oncol; 2005 Dec; 27(4):248-56. PubMed ID: 16404342
[TBL] [Abstract][Full Text] [Related]
4. Ethanol-inducible cytochrome P4502E1: regulation, enzymology and molecular biology.
Ingelman-Sundberg M; Ronis MJ; Lindros KO; Eliasson E; Zhukov A
Alcohol Alcohol Suppl; 1994; 2():131-9. PubMed ID: 8974327
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
Morita M; Le Marchand L; Kono S; Yin G; Toyomura K; Nagano J; Mizoue T; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Imaizumi N
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):235-41. PubMed ID: 19124503
[TBL] [Abstract][Full Text] [Related]
6. Role of the genetic polymorphisms in the 5'-flanking region for transcriptional regulation of the human CYP2E1 gene.
Uchimoto T; Itoga S; Nezu M; Sunaga M; Tomonaga T; Nomura F
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S36-42. PubMed ID: 17331164
[TBL] [Abstract][Full Text] [Related]
7. Genetic repeat polymorphism in the regulating region of CYP2E1: frequency and relationship with enzymatic activity in alcoholics.
Plee-Gautier E; Foresto F; Ferrara R; Bodénez P; Simon B; Manno M; Berthou F; Lucas D
Alcohol Clin Exp Res; 2001 Jun; 25(6):800-4. PubMed ID: 11410713
[TBL] [Abstract][Full Text] [Related]
8. Xenobiotic-enhanced expression of cytochromes P450 2E1 and 2B in primary cultured rat hepatocytes.
Woodcroft KJ; Novak RF
Drug Metab Dispos; 1998 Apr; 26(4):372-8. PubMed ID: 9531527
[TBL] [Abstract][Full Text] [Related]
9. Investigation of xenobiotics metabolism, genotoxicity, and carcinogenicity using Cyp2e1(-/-) mice.
Ghanayem BI; Hoffler U
Curr Drug Metab; 2007 Oct; 8(7):728-49. PubMed ID: 17979661
[TBL] [Abstract][Full Text] [Related]
10. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation of CYP2E1 activity by cAMP-dependent protein kinase upon Ser129 replacement.
Oesch-Bartlomowicz B; Padma PR; Becker R; Richter B; Hengstler JG; Freeman JE; Wolf CR; Oesch F
Exp Cell Res; 1998 Jul; 242(1):294-302. PubMed ID: 9665827
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver, kidney, and nose of male mice.
Constan AA; Sprankle CS; Peters JM; Kedderis GL; Everitt JI; Wong BA; Gonzalez FL; Butterworth BE
Toxicol Appl Pharmacol; 1999 Oct; 160(2):120-6. PubMed ID: 10527910
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1.
Lin DX; Tang YM; Peng Q; Lu SX; Ambrosone CB; Kadlubar FF
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1013-8. PubMed ID: 9829710
[TBL] [Abstract][Full Text] [Related]
14. Interaction between cytochrome P-450 2E1 polymorphisms and environmental factors with risk of esophageal and stomach cancers in Chinese.
Gao C; Takezaki T; Wu J; Li Z; Wang J; Ding J; Liu Y; Hu X; Xu T; Tajima K; Sugimura H
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):29-34. PubMed ID: 11815398
[TBL] [Abstract][Full Text] [Related]
15. Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)--a review.
Lieber CS
Alcohol Clin Exp Res; 1999 Jun; 23(6):991-1007. PubMed ID: 10397283
[TBL] [Abstract][Full Text] [Related]
16. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
17. Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk.
Le Marchand L; Donlon T; Seifried A; Wilkens LR
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1019-24. PubMed ID: 12376502
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of CYP2E1 and risk of colorectal adenomas in the Self Defense Forces Health Study.
Morita M; Tabata S; Tajima O; Yin G; Abe H; Kono S
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1800-7. PubMed ID: 18628434
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of ethyl carbamate by pulmonary cytochrome P450 and carboxylesterase isozymes: involvement of CYP2E1 and hydrolase A.
Forkert PG; Lee RP
Toxicol Appl Pharmacol; 1997 Oct; 146(2):245-54. PubMed ID: 9344892
[TBL] [Abstract][Full Text] [Related]
20. [Association analysis of gene polymorphism in alcohol metabolizing enzymes with risk for coronary atherosclerosis].
Marusin AV; Stepanov VA; Spiridonova MG; Khar'kov VA; Pel's IaR; Puzyrev VP
Genetika; 2007 Mar; 43(3):409-16. PubMed ID: 17486761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
